VAR2 Pharmaceuticals is attending the American Association Cancer Research Annual Meeting taking place in California between April 17 and 22. Our Executive Chairman of the Board and company co-founder Mads Daugaard will be on site and presenting a poster (CT112) on the clinical validation of our anti-oncofetal chondroitin sulfate Vartumabs in our ongoing Phase 0 […]
